Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Payables: 2009-2021

Historic Payables for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to $7.7 million.

  • Avadel Pharmaceuticals' Payables fell 63.94% to $2.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $23.5 million, marking a year-over-year increase of 32.54%. This contributed to the annual value of $7.7 million for FY2021, which is 161.72% up from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Payables of $7.7 million as of FY2021, which was up 161.72% from $2.9 million recorded in FY2020.
  • Avadel Pharmaceuticals' Payables' 5-year high stood at $7.7 million during FY2021, with a 5-year trough of $2.9 million in FY2020.
  • In the last 3 years, Avadel Pharmaceuticals' Payables had a median value of $6.1 million in 2019 and averaged $5.6 million.
  • In the last 5 years, Avadel Pharmaceuticals' Payables tumbled by 53.15% in 2018 and then skyrocketed by 161.72% in 2021.
  • Over the past 5 years, Avadel Pharmaceuticals' Payables (Yearly) stood at $7.5 million in 2017, then crashed by 53.15% to $3.5 million in 2018, then soared by 74.14% to $6.1 million in 2019, then slumped by 51.90% to $2.9 million in 2020, then soared by 161.72% to $7.7 million in 2021.